News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

Flash

News

Markets

VIP news

Calendar

All

Crypto

Stocks

Commodities & Forex

Macro

Ethereum Holds Steady Amid Market Drop—but $4,500 Remains the Key Reversal Zone

Ethereum is poised for further gains but faces significant resistance at $4,500. Profit-taking by investors could slow its rise, with support at $3,742 offering stability if selling pressure intensifies. Ask ChatGPT Ethereum is poised for further gains but faces significant resistance at $4,500. Profit-taking by investors could slow its rise, with support at $3,742 offering stability if selling pressure intensifies.

BeInCrypto·2025/07/31 15:30

ETH Reserves Cross $10B Across 64 Strategic Entities

Total ETH reserves held by 64 strategic entities now exceed $10 billion, signaling strong institutional confidence.Ethereum’s Institutional Demand Continues to RiseWhat This Means for Retail Investors

Coinomedia·2025/07/31 15:25

XRP Double Bottom Pattern Signals Possible Breakout

XRP may confirm a double bottom pattern with a breakout above $3.30, targeting $3.60 next.Breakout Above $3.30 Is KeyWhat Traders Should Watch Next

Coinomedia·2025/07/31 15:25

Bitcoin’s 5-Wave Pattern Signals New Rally

Bitcoin’s classic 5-wave structure returns, mirroring early 2024’s setup that sparked a massive rally. Is another breakout coming?Is Bitcoin Gearing Up for Another Surge?What This Means for Crypto Investors

Coinomedia·2025/07/31 15:25

Whales Buying Bitcoin as Retail Investors Exit

While retail investors sell, large Bitcoin holders are increasing their positions amid growing institutional interest.Retail Selling Could Signal Short-Term CautionThe Big Picture: Whales vs. Retail

Coinomedia·2025/07/31 15:25

Visa Expands Stablecoin Support to PYUSD, USDG & EURC

Visa adds PYUSD, USDG, and EURC to its stablecoin roster, integrating with Stellar and Avalanche for faster onchain settlements.New Blockchains Join the NetworkWhat This Means for Crypto Payments

Coinomedia·2025/07/31 15:25

Pump.fun (PUMP) Price Prediction for August 2025

CryptoNewsNet·2025/07/31 15:20

Here’s XRP Price If It Maintains 4% Dominance in a $50 Trillion Crypto Market

CryptoNewsNet·2025/07/31 15:20

Crypto’s Golden Age Starts But Altseason Falters: Here’s Why

CryptoNewsNet·2025/07/31 15:20

Grayscale Story Trust Unveils Exciting New Frontier for Digital Rights Investment

BitcoinWorld·2025/07/31 15:15

Flash

11:45

SpaceX perpetual futures remain effectively priced, while spot token issuance faces setbacks.

According to Bloomberg, SpaceX perpetual futures accurately reflected market sentiment and converged to the stock trading range before the Nasdaq opened, but the SpaceX stock tokenization product was ultimately forced to refund as the trading platform failed to obtain enough underlying shares.

11:41

SK Hynix rumored to launch a shareholder return plan worth hundreds of trillions of won, official response: The specific scale has never been discussed.

SK Hynix responded to Jiemian News stating that it is "exploring various options to enhance shareholder value, but the company has never discussed specific details such as the scale of shareholder returns mentioned in the relevant reports." Previously, The Korea Economic Daily reported that SK Hynix planned to launch an ultra-large shareholder return policy worth 100 trillion Korean won in the fourth quarter of this year, with specific measures including share buybacks and cash dividends. This move was interpreted by outsiders as a major strategic bet by SK Group Chairman Chey Tae-won, aiming to enhance the company’s position and valuation in the global capital market through large-scale shareholder returns.

11:40

Moderna, Inc. recently revealed that the company is actively planning its future product pipeline, and it is expected that as many as three new vaccine products may be launched between 2027 and 2028.

These potential new products include a combined vaccine that protects against both influenza and COVID-19, an updated vaccine for seasonal influenza, and a new vaccine designed to prevent norovirus infection. This plan highlights Moderna’s ongoing expansion and in-depth application of its mRNA technology platform. The company is committed to extending its core mRNA research and development capabilities from the successful response to the COVID-19 pandemic to a broader range of respiratory and even gastrointestinal infectious diseases. If the combined influenza and COVID-19 vaccine is successfully launched, it could simplify public health immunization procedures and provide people with more convenient and comprehensive protection options. The development of a norovirus vaccine marks an important step for the company into a new field of disease prevention.Market analysts have pointed out that if this product pipeline plan progresses smoothly, it could open up new growth opportunities for Moderna in the coming years and strengthen its leading position in the global biotechnology and vaccine sectors. Investors are closely monitoring the progress of these research and development projects as well as their commercialization prospects.

Trending news

Abu Dhabi Airport Moves Toward Bitcoin Payments With New Crypto Wallet Pilot

Will Solana price rejoin its former consolidation range as it nears $75?

Bitget

News